A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
收藏DataCite Commons2025-10-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011873/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety and effectiveness of Baricitinib in eczema.
提供机构：
Vivli
创建时间：
2025-10-17
